Skip to main content
Prion logoLink to Prion
. 2013 Mar 1;7(2):127–130. doi: 10.4161/pri.22851

The prion protein family

Looking outside the central nervous system

Bruno Passet 1, Sophie Halliez 2, Vincent Béringue 2, Hubert Laude 2, Jean-Luc Vilotte 1,*
PMCID: PMC3609118  PMID: 23154632

Abstract

Although the pivotal implication of the host-encoded Prion protein, PrP, in the neuropathology of transmissible spongiform encephalopathy is known for decades, its biological role remains mostly elusive. Genetic inactivation is one way to assess such issue but, so far, PrP-knockout mice did not help much. However, recent reports involving (1) further studies of these mice during embryogenesis, (2) knockdown experiments in Zebrafish and (3) knockdown of Shadoo, a protein with PrP-like functional domains, in PrP-knockout mice, all suggested a role of the Prion protein family in early embryogenesis. This view is challenged by the recent report that PrP/Shadoo knockout mice are healthy and fertile. Although puzzling, these apparently contradictory data may on the contrary help at deciphering the Prion protein family role through focusing scientific attention outside the central nervous system and by helping the identification of other loci involved in the genetic robustness associated with PrP.

Keywords: Shadoo, doppel, prion, PrP, embryo, placenta, trophectoderm, stem cell


Prion diseases or Transmissible Spongiform Encephalopathies (TSE) are a related group of rare, fatal brain-neurodegenerative diseases that affect animals and humans.1 The isolation of the disease-associated protein, PrPSc, found to be the major, if not the sole, component of the infectious agent, led to the protein only hypothesis.2 This protease resistant protein was later found to result from the conformational conversion of a cellular glycosylphosphatidylinositol-anchored host glycoprotein, PrPc. PrPc is encoded by the Prnp gene. PrP primary and tertiary structures are well conserved among mammals. This protein is expressed in a broad range of vertebrate tissues and most abundantly in the central nervous system (CNS).3 Thus, among other approaches, many studies have focused on the analysis of the potential biological role of PrP in the CNS, indirectly helping deciphering the neurotoxicity associated with PrPSc.

PrP Biological Enigma

It was highly anticipated that the genetic ablation of the Prnp gene will allow the identification of the PrPC biological function. It came as a surprise that its knockout in mice,4,5 cattle6 and goat7 were obtained with no drastic developmental phenotype. Its post-natal depletion in adult neurons resulted in similar observations.8,9 The only clear phenotype that knockout mice developed was their absolute resistance to TSE and to the neurotoxicity associated with PrPSc. However, PrPC was reported to be involved in various physiological and developmental functions (see refs. 10 and 11 for recent reviews). To explain these apparent discrepancies, it was hypothesized that a host-encoded gene could compensate for the lack of PrP.12 Such a host-encoded gene should thus share with PrP at least two characteristics: (1) an overlapping pattern of expression at a developing time and in cells where PrP has a crucial role and (2) a related biological function so that one can compensate the absence of the other either through strict redundancy or by modulating parallel pathways.

PrP Paralogs

In the last decade, two mammalian paralogs of PrP, Doppel and Shadoo, were discovered (see ref. 13 for review). These three loci probably derived by retro-transposition of an ancestral ZIP metal ion transporter gene.14 Doppel and Shadoo were demonstrated to be of neurological relevance. Doppel is normally mainly expressed in the testis of adult mammals and its ectopic expression can cause neuro-degeneration in the central nervous system (CNS). Shadoo is expressed in the CNS and both Shadoo and PrP share neuro-protective properties, notably against Doppel and N-terminally-truncated PrP neurotoxicities.15 However, as mentioned above, Doppel is not normally expressed in the adult CNS and careful examination of the pattern of expression of Shadoo in the adult brain revealed that it did not fully overlap that of PrP.16 These observations suggested that should Doppel and/or Shadoo be the putative host-encoded protein that compensate for the lack of PrP, such an effect should be searched elsewhere than in the adult brain.

Genetic Depletion of Several Members of the Prion Protein Family

Genetic depletion in transgenic mice of PrP and Shadoo16 and of PrP and Doppel17,18 have been published. The co-depletion of PrP and Doppel produced a phenotype identical to that of Doppel single knockout. The co-inactivation of PrP and Shadoo produced viable and fertile mice, although the output of crosses between SprnKOPrnpKO x SprnKOPrnpKO mice was not apparently assessed (Table S1 in16). Shadoo knockout mice only suffered from a subtle alteration of the body weight which was not documented in the double-knockout mice16 (Table1). Altogether, these observations lent support to the view that PrP and Shadoo on one side, Doppel and PrP on the other, have no-overlapping/redundant roles.

Table 1. Survey of the phenotypic results associated with PrP and/or Shadoo genetic manipulation.

Mouse genotype Trophectoderm Phenotype ? Litter Phenotype ?
PrP knockout23
Decreased Placental Weights
Compaction of the labyrinth
Lower body weights
Shadoo knockout16
Not tested
Lower body weights
PrP Knockout, Shadoo Knockdown19,20
Ectoplacental cone defect
Embryonic lethality
PrP and Shadoo Knockout16 Not tested Not reported

The outcome of the Shadoo-PrP double gene inactivation is discrepant with our previously published data that described early embryonic lethality in mice knockout for PrP and knockdown by RNA interference for Shadoo19 (Table1). Origin of this lethality was recently found to result from a developmental failure of the trophectoderm-derived compartment.20 RNA interference is known to potentially induce knockdown of off-targets and thus false phenotypes. However, since it was observed with two independent ShRNAs targeting the Shadoo mRNA, it seems unlikely that this is at the origin of the observed lethality. Furthermore, an attractive alternative hypothesis, that the ShRNA were also targeting the Mtg1 transcript that overlaps the 3′-end of the Shadoo transcript,16,21 could be dismissed by (1) the locations of the ShRNA targeted sequences outside the overlapping region19 and (2) the absence of differential expression of the Mtg1 transcript in the Shadoo knockdown embryos.20 Instead, recent data from the literature appear to be in frame with the induced embryonic lethal phenotype and to indirectly comfort this observation.

PrP and ShadooI in the Trophoblastic Cell Lineages

Expression of PrP during embryonic development, including in the extra-embryonic tissue, had already being described.22,23 Knockout of the PrP gene was recently shown to induce intrauterine growth retardation24 (Table 1). This phenotype, which is also associated with significant lower body weights in the adulthood, was attributed to an impairment of the trophoblast angiogenic function in PrP-deficient embryos and suggested a role for PrP in the development of the placental zones associated with invasion of the trophoblast cells into the maternal deciduas. Such an induced phenotype could appear congruent with the regulatory role on embryonic cell adhesion attributed to PrP1 in Zebrafish25 and with the biological pathways identified by comparative transcriptomic analysis of PrP and PrP-knockout early mouse embryos: cell mobility and angiogenesis.25

Shadoo was also recently found to be expressed in the trophoblast cells of the placenta.20,27 Furthermore, comparative transcriptomic analyses performed between E6.5 and E7.5 Shadoo-knockdown embryos and their wild-type counterparts suggested that Shadoo has functions complementary, not necessary overlapping, with those of PrP, associated with cellular movement and hematological system development and differentiation.20 In the knockout experiment, it was reported that a relationship probably exists between levels of Shadoo expression and body mass16 (Table 1). It was suggested that this relationship could be associated with the observed natural expression of Shadoo in hypothalamic neurons since this neuro-anatomical structure contains nuclei that control feeding behavior.21 An alternative explanation, yet to be substantiated, would be that this relationship is a consequence of a placental developmental defect, as observed for PrP. The reported difference observed in the mean litter size of Shadoo-knockout mice (7 vs. 7.4, Table S1 in16) could indirectly support this latter hypothesis.

Potential Future Directions

What then could explain the difference in the outcome between the double knockout and the knockout/knockdown approaches? A classical explanation for such differences is the use of different genetic backgrounds. Although, as previously stated,21 the two used genetic backgrounds (FVB/N for the knockdown19 vs. FVB/NCr x 129Pas for the knockout16) are not very different, it should be noted that neurological signs were observed in aged FVB/NCr x 129Pas but not in aged FVB/N PrP-knockout mice.16 Thus, although similar, these two genetic backgrounds differ. An experimental approach to solve this question would be to invalidate the Shadoo locus specifically in the FVB/N genetic background. We are currently performing such an approach using zinc-finger-nucleases.28 If it confirms that the double genetic depletion of PrP and Shadoo is lethal in the FVB/N genetic background, its comparison with the FVB/NCr x 129Pas one would be of great interest to identify partners of PrP and Shadoo in controlling the development and differentiation of the trophoblastic cell lineages. Furthermore, a trophoblastic-restricted rescue of Shadoo expression would then also allow to assess whether the development and/or differentiation of embryonic lineage(s) is (are) also affected by the double-gene knockout in FVB/N mice.

Should the double gene knockout turn out to be viable in the FVB/N genetic background, alternative hypotheses could be tested. A potential compensation phenomenon by other genes has already been discussed and will not be further detailed here.21 Another possibility is that the double-knockout mice are more sensitive to biological stress. PrP was recently shown to interact with Argonaute and to be involved in the regulation of the microRNA-induced silencing complexes (RISCs).29 It was noted that Shadoo might compensate for the lack of PrP and that the observed age of lethality of the PrP-knockout/Shadoo-knockdown embryos is reminiscent of that of Dicer knockout embryos.28 The knockdown experiment induces high level of expression of ShRNA that have to be incorporated into RISCs. Such a perturbation might be detrimental in transgenic mice harboring altered RISCs due to the absence of both PrP and Shadoo. It would be easy to test this hypothesis by challenging the double PrP and Shadoo knockout mice with various ShRNA expressing cassettes. Alternatively, lentiviral infection by itself might cause a biological stress.

Although we could exclude that a knockdown of Mtg1 was at the origin of the lethal phenotype as suggested16,21 (see discussion above), it remains possible that the two ShRNA were indeed targeting other transcript(s). Because of their location and sequence specificity, an attractive hypothesis would be that they also target a yet unknown transcript that overlaps the last exon of the Shadoo gene, such as for instance a long non-coding RNA.30 Such transcripts are implicated in various biological functions and often overlap gene’s transcription units. Its sequence, but not necessarily its expression, would be partially affected by the knockout process, leaving the possibility that it remains active. Whatever the ShRNA target transcript beside Shadoo is, its identification would be of great interest as its depletion induces a phenotype only in a PrP-knockout genetic background. Its identification would be facilitated by comparative transcriptomic analysis of ShRNA treated or not Shadoo-knockout embryos, which would allow to get rid of the perturbations associated with Shadoo depletion itself.

Thus although the phenotypic difference between the PrP/Shadoo knockout and knockdown mice is puzzling, it raises fascinating biological questions on the potential involvement of these two genes in early mammalian embryogenesis alongside a yet unknown locus. Elucidating the role of this protein family could have medical implication since expression of PrP was noticed to be deregulated in human placental pathologies.29 It would also be tempting to similarly study the role of Doppel, which is also expressed at these early developmental stages in mouse (our own unpublished observation). We are currently assessing this point using again a ZFN approach.

Acknowledgments

The authors are supported by the French ANR-09-BLAN-0015–01.

Passet B, Young R, Makhzami S, Vilotte M, Jaffrezic F, Halliez S, Bouet S, Marthey S, Khalifé M, Kanellopoulos-Langevin C, Béringue V, Le Provost F, Laude H, Vilotte JL. Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development. PLoS One. 2012;7:e41959. doi: 10.1371/journal.pone.0041959.

Footnotes

References

  • 1.Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell. 2004;116:313–27. doi: 10.1016/S0092-8674(03)01031-6. [DOI] [PubMed] [Google Scholar]
  • 2.Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–44. doi: 10.1126/science.6801762. [DOI] [PubMed] [Google Scholar]
  • 3.Bendheim PE, Brown HR, Rudelli RD, Scala LJ, Goller NL, Wen GY, et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology. 1992;42:149–56. doi: 10.1212/WNL.42.1.149. [DOI] [PubMed] [Google Scholar]
  • 4.Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992;356:577–82. doi: 10.1038/356577a0. [DOI] [PubMed] [Google Scholar]
  • 5.Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol. 1994;8:121–7. doi: 10.1007/BF02780662. [DOI] [PubMed] [Google Scholar]
  • 6.Richt JA, Kasinathan P, Hamir AN, Castilla J, Sathiyaseelan T, Vargas F, et al. Production of cattle lacking prion protein. Nat Biotechnol. 2007;25:132–8. doi: 10.1038/nbt1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yu G, Chen J, Xu Y, Zhu C, Yu H, Liu S, et al. Generation of goats lacking prion protein. Mol Reprod Dev. 2009;76:3. doi: 10.1002/mrd.20960. [DOI] [PubMed] [Google Scholar]
  • 8.Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG, et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 2002;21:202–10. doi: 10.1093/emboj/21.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A. 2008;105:10238–43. doi: 10.1073/pnas.0802759105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev. 2008;88:673–728. doi: 10.1152/physrev.00007.2007. [DOI] [PubMed] [Google Scholar]
  • 11.Lopes MH, Santos TG. Prion potency in stem cell biology. Prion. 2012;6:1–5. doi: 10.4161/pri.19035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shmerling D, Hegyi I, Fischer M, Blättler T, Brandner S, Götz J, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell. 1998;93:203–14. doi: 10.1016/S0092-8674(00)81572-X. [DOI] [PubMed] [Google Scholar]
  • 13.Westaway D, Daude N, Wohlgemuth S, Harrison P. The PrP-like proteins Shadoo and Doppel. Top Curr Chem. 2011;305:225–56. doi: 10.1007/128_2011_190. [DOI] [PubMed] [Google Scholar]
  • 14.Ehsani S, Tao R, Pocanschi CL, Ren H, Harrison PM, Schmitt-Ulms G. Evidence for retrogene origins of the prion gene family. PLoS One. 2011;6:e26800. doi: 10.1371/journal.pone.0026800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Watts JC, Drisaldi B, Ng V, Yang J, Strome B, Horne P, et al. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections. EMBO J. 2007;26:4038–50. doi: 10.1038/sj.emboj.7601830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Daude N, Wohlgemuth S, Brown R, Pitstick R, Gapeshina H, Yang J, et al. Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrP(C)-deficiency. Proc Natl Acad Sci U S A. 2012;109:9035–40. doi: 10.1073/pnas.1202130109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Behrens A, Genoud N, Naumann H, Rülicke T, Janett F, Heppner FL, et al. Absence of the prion protein homologue Doppel causes male sterility. EMBO J. 2002;21:3652–8. doi: 10.1093/emboj/cdf386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Paisley D, Banks S, Selfridge J, McLennan NF, Ritchie AM, McEwan C, et al. Male infertility and DNA damage in Doppel knockout and prion protein/Doppel double-knockout mice. Am J Pathol. 2004;164:2279–88. doi: 10.1016/S0002-9440(10)63784-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Young R, Passet B, Vilotte M, Cribiu EP, Béringue V, Le Provost F, et al. The prion or the related Shadoo protein is required for early mouse embryogenesis. FEBS Lett. 2009;583:3296–300. doi: 10.1016/j.febslet.2009.09.027. [DOI] [PubMed] [Google Scholar]
  • 20.Passet B, Young R, Makhzami S, Vilotte M, Jaffrezic F, Halliez S, et al. Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development. PLoS One. 2012;7:e41959. doi: 10.1371/journal.pone.0041959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Daude N, Westaway D. Shadoo/PrP (Sprn ( 0/0) /Prnp ( 0/0) ) double knockout mice: More than zeroes. Prion. 2012;7 doi: 10.4161/pri.21867. [Epub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tremblay P, Bouzamondo-Bernstein E, Heinrich C, Prusiner SB, DeArmond SJ. Developmental expression of PrP in the post-implantation embryo. Brain Res. 2007;1139:60–7. doi: 10.1016/j.brainres.2006.12.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J. The prion protein gene: a role in mouse embryogenesis? Development. 1992;115:117–22. doi: 10.1242/dev.115.1.117. [DOI] [PubMed] [Google Scholar]
  • 24.Alfaidy N, Chauvet S, Andrei S, Salomon A, Saoudi Y, Richaud PR, et al. Prion Protein Expression and Functional Importance in Developmental Angiogenesis: Role in Oxidative Stress and Copper Homeostasis. Antioxid Redox Signal. 2012 doi: 10.1089/ars.2012.4637. [Epub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 25.Málaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, et al. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol. 2009;7:e55. doi: 10.1371/journal.pbio.1000055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Khalifé M, Young R, Passet B, Halliez S, Vilotte M, Jaffrezic F, et al. Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis. PLoS One. 2011;6:e23253. doi: 10.1371/journal.pone.0023253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Young R, Bouet S, Polyte J, Le Guillou S, Passet B, Vilotte M, et al. Expression of the prion-like protein Shadoo in the developing embryo. Biochem Biophys Res Commun. 2011;416:184–7. doi: 10.1016/j.bbrc.2011.11.021. [DOI] [PubMed] [Google Scholar]
  • 28.Carbery ID, Ji D, Harrington A, Brown V, Weinstein EJ, Liaw L, et al. Targeted genome modification in mice using zinc-finger nucleases. Genetics. 2010;186:451–9. doi: 10.1534/genetics.110.117002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gibbings D, Leblanc P, Jay F, Pontier D, Michel F, Schwab Y, et al. Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes. Nat Struct Mol Biol. 2012;19:517–24, S1. doi: 10.1038/nsmb.2273. [DOI] [PubMed] [Google Scholar]
  • 30.Hwang HS, Park SH, Park YW, Kwon HS, Sohn IS. Expression of cellular prion protein in the placentas of women with normal and preeclamptic pregnancies. Acta Obstet Gynecol Scand. 2010;89:1155–61. doi: 10.3109/00016349.2010.498497. [DOI] [PubMed] [Google Scholar]

Articles from Prion are provided here courtesy of Taylor & Francis

RESOURCES